These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6357536)

  • 1. Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
    Liang CS; Sherman LG; Doherty JU; Wellington K; Lee VW; Hood WB
    Circulation; 1984 Jan; 69(1):113-9. PubMed ID: 6357536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced conditioning in congestive heart failure.
    Leier CV; Huss P; Lewis RP; Unverferth DV
    Circulation; 1982 Jun; 65(7):1382-7. PubMed ID: 7074796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
    Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
    Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outpatient dobutamine infusion using a totally implantable infusion pump for refractory congestive heart failure.
    Berger M; McSherry CK
    Chest; 1985 Aug; 88(2):295-6. PubMed ID: 4017685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent dobutamine hydrochloride infusions in outpatients with chronic congestive heart failure.
    Roffman DS; Applefeld MM; Grove WR; Talesnick BS; Sutton FJ; Newman KA; Reed WP
    Clin Pharm; 1985; 4(2):195-9. PubMed ID: 3987220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
    Scrutinio D; Napoli V; Passantino A; Ricci A; Lagioia R; Rizzon P
    Eur Heart J; 2000 Jun; 21(11):927-34. PubMed ID: 10806017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
    Leier CV; Webel J; Bush CA
    Circulation; 1977 Sep; 56(3):468-72. PubMed ID: 884803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
    Erlemeier HH; Kupper W; Bleifeld W
    Cardiovasc Drugs Ther; 1992 Aug; 6(4):391-8. PubMed ID: 1520649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
    Pacher R; Globits S; Wutte M; Rödler S; Heinz G; Kreiner G; Radosztics S; Berger R; Presch I; Weber H
    Crit Care Med; 1994 Jul; 22(7):1084-90. PubMed ID: 8026195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure.
    Applefeld MM; Newman KA; Grove WR; Sutton FJ; Roffman DS; Reed WP; Linberg SE
    Am J Cardiol; 1983 Feb; 51(3):455-8. PubMed ID: 6823859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
    Klein NA; Siskind SJ; Frishman WH; Sonnenblick EH; LeJemtel TH
    Am J Cardiol; 1981 Jul; 48(1):170-5. PubMed ID: 7246440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
    Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
    Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    Dubois-Randé JL; Comoy E; Merlet P; Benvenuti C; Carville C; Hittinger L; Macquin-Mavier I; Bohuon C; Castaigne A
    Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training.
    Liang C; Tuttle RR; Hood WB; Gavras H
    J Clin Invest; 1979 Aug; 64(2):613-9. PubMed ID: 457872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
    Marcus RH; Raw K; Patel J; Mitha A; Sareli P
    Am J Cardiol; 1990 Nov; 66(15):1107-12. PubMed ID: 2220638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure.
    Maskin CS; Forman R; Sonnenblick EH; Frishman WH; LeJemtel TH
    Am J Cardiol; 1983 Jan; 51(1):177-82. PubMed ID: 6849256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure.
    Jondeau G; Dubourg O; Delorme G; Arnal JF; Chikli F; Kamoun L; Dumas C; Bourdarias JP
    Eur Heart J; 1994 Feb; 15(2):242-6. PubMed ID: 8005127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure.
    Gibelin P; Sbirrazzuoli V; Drici M; Camous JP; Lapalus P; Morand P
    Cardiovasc Drugs Ther; 1990 Aug; 4(4):1105-11. PubMed ID: 1964577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to dobutamine after a 72 hour continuous infusion.
    Unverferth DA; Blanford M; Kates RE; Leier CV
    Am J Med; 1980 Aug; 69(2):262-6. PubMed ID: 7405947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.